PLUR
Price
$4.95
Change
-$0.32 (-6.07%)
Updated
Sep 2, 04:00 PM (EDT)
Capitalization
41.48M
RLMD
Price
$1.43
Change
+$0.31 (+27.68%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
37.17M
65 days until earnings call
Interact to see
Advertisement

PLUR vs RLMD

Header iconPLUR vs RLMD Comparison
Open Charts PLUR vs RLMDBanner chart's image
Pluri
Price$4.95
Change-$0.32 (-6.07%)
Volume$100
Capitalization41.48M
Relmada Therapeutics
Price$1.43
Change+$0.31 (+27.68%)
Volume$25.21K
Capitalization37.17M
PLUR vs RLMD Comparison Chart in %
Loading...
PLUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLUR vs. RLMD commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLUR is a StrongBuy and RLMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (PLUR: $5.27 vs. RLMD: $1.12)
Brand notoriety: PLUR and RLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLUR: 45% vs. RLMD: 2753%
Market capitalization -- PLUR: $41.48M vs. RLMD: $37.17M
PLUR [@Biotechnology] is valued at $41.48M. RLMD’s [@Biotechnology] market capitalization is $37.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLUR’s FA Score shows that 0 FA rating(s) are green whileRLMD’s FA Score has 1 green FA rating(s).

  • PLUR’s FA Score: 0 green, 5 red.
  • RLMD’s FA Score: 1 green, 4 red.
According to our system of comparison, RLMD is a better buy in the long-term than PLUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLUR’s TA Score shows that 4 TA indicator(s) are bullish while RLMD’s TA Score has 5 bullish TA indicator(s).

  • PLUR’s TA Score: 4 bullish, 5 bearish.
  • RLMD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RLMD is a better buy in the short-term than PLUR.

Price Growth

PLUR (@Biotechnology) experienced а -7.22% price change this week, while RLMD (@Biotechnology) price change was +78.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

RLMD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLUR($41.5M) has a higher market cap than RLMD($37.2M). RLMD YTD gains are higher at: 115.385 vs. PLUR (23.275). PLUR has higher annual earnings (EBITDA): -20.22M vs. RLMD (-70.52M). PLUR has more cash in the bank: 26.3M vs. RLMD (20.6M). RLMD has less debt than PLUR: RLMD (256K) vs PLUR (31.2M). PLUR has higher revenues than RLMD: PLUR (1.03M) vs RLMD (0).
PLURRLMDPLUR / RLMD
Capitalization41.5M37.2M112%
EBITDA-20.22M-70.52M29%
Gain YTD23.275115.38520%
P/E RatioN/AN/A-
Revenue1.03M0-
Total Cash26.3M20.6M128%
Total Debt31.2M256K12,188%
FUNDAMENTALS RATINGS
PLUR vs RLMD: Fundamental Ratings
PLUR
RLMD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
5135
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RLMD's Valuation (28) in the null industry is significantly better than the same rating for PLUR (98) in the Biotechnology industry. This means that RLMD’s stock grew significantly faster than PLUR’s over the last 12 months.

RLMD's Profit vs Risk Rating (100) in the null industry is in the same range as PLUR (100) in the Biotechnology industry. This means that RLMD’s stock grew similarly to PLUR’s over the last 12 months.

RLMD's SMR Rating (99) in the null industry is in the same range as PLUR (100) in the Biotechnology industry. This means that RLMD’s stock grew similarly to PLUR’s over the last 12 months.

RLMD's Price Growth Rating (35) in the null industry is in the same range as PLUR (51) in the Biotechnology industry. This means that RLMD’s stock grew similarly to PLUR’s over the last 12 months.

RLMD's P/E Growth Rating (100) in the null industry is in the same range as PLUR (100) in the Biotechnology industry. This means that RLMD’s stock grew similarly to PLUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLURRLMD
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
86%
Momentum
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
87%
MACD
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
87%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
PLUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOMO8.300.17
+2.09%
Hello Group
WILC20.490.24
+1.18%
G Willi-Food International Ltd
MUFG15.29-0.11
-0.71%
Mitsubishi UFJ Financial Group
KBR50.46-0.82
-1.60%
KBR
ECOR5.31-0.19
-3.45%
electroCore

PLUR and

Correlation & Price change

A.I.dvisor tells us that PLUR and RZLT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLUR and RZLT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLUR
1D Price
Change %
PLUR100%
+1.93%
RZLT - PLUR
29%
Poorly correlated
-1.39%
RLMD - PLUR
28%
Poorly correlated
+44.52%
BNTX - PLUR
28%
Poorly correlated
-1.89%
BEAM - PLUR
26%
Poorly correlated
-2.91%
STRO - PLUR
26%
Poorly correlated
-4.28%
More

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with ENTO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
+44.52%
ENTO - RLMD
35%
Loosely correlated
+5.81%
ARGNF - RLMD
31%
Poorly correlated
N/A
REVB - RLMD
30%
Poorly correlated
-1.08%
PLUR - RLMD
28%
Poorly correlated
+1.93%
TPST - RLMD
26%
Poorly correlated
+0.71%
More